Cargando…
Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation
We sought novel strategies to reduce levels of the polyglutamine androgen receptor (polyQ AR) and achieve therapeutic benefits in models of spinobulbar muscular atrophy (SBMA), a protein aggregation neurodegenerative disorder. Proteostasis of the polyQ AR is controlled by the Hsp90/Hsp70-based chape...
Autores principales: | Wang, Adrienne M., Miyata, Yoshinari, Klinedinst, Susan, Peng, Hwei-Ming, Chua, Jason P., Komiyama, Tomoko, Li, Xiaokai, Morishima, Yoshihiro, Merry, Diane E., Pratt, William B., Osawa, Yoichi, Collins, Catherine A., Gestwicki, Jason E., Lieberman, Andrew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552084/ https://www.ncbi.nlm.nih.gov/pubmed/23222885 http://dx.doi.org/10.1038/nchembio.1140 |
Ejemplares similares
-
Dynamic cycling with a unique Hsp90/Hsp70-dependent chaperone machinery and GAPDH is needed for heme insertion and activation of neuronal NO synthase
por: Morishima, Yoshihiro, et al.
Publicado: (2022) -
Multivalent protein–protein interactions are pivotal regulators of eukaryotic Hsp70 complexes
por: Johnson, Oleta T., et al.
Publicado: (2022) -
HSP70 interacting protein prevents the accumulation of inclusions in polyglutamine disease(1)
por: Howarth, Joanna L, et al.
Publicado: (2009) -
De novo designed Hsp70 activator dissolves intracellular condensates
por: Zhang, Jason Z, et al.
Publicado: (2023) -
Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor
por: Eftekharzadeh, Bahareh, et al.
Publicado: (2019)